Results 101 to 110 of about 6,029 (168)
Biosimilars: potential implications for clinicians
Misty G Eleryan,1 Sophia Akhiyat,2 Monica Rengifo-Pardo,1 Alison Ehrlich,1,2 1Department of Dermatology, The George Washington Medical Faculty Associates, 2George Washington University School of Medicine & Health Sciences, Washington, DC, USA ...
Eleryan MG +3 more
doaj
Clinical perspectives of emerging pathogens in bleeding disorders. [PDF]
As a result of immunological and nucleic-acid screening of plasma donations for transfusion-transmissible viruses, and the incorporation of viral reduction processes during plasma fractionation, coagulation-factor concentrates (CFC) are now judged safe ...
Bozzette, Samuel +11 more
core +1 more source
Keeping Tabs on Financial Innovation: Product Identifiers in Consumer Financial Regulation [PDF]
The financial crisis of 2008 gave rise to renewed discussion about whether financial innovations should undergo higher scrutiny for potential harm and, if so, what type?
Carpenter, Daniel, McCoy, Patricia A.
core +1 more source
La presente investigación caracterizó las notificaciones de sospechas de reacciones adversas medicamentosas en personas mayores de 60 años, recibidas en la Unidad Coordinadora Provincial de Farmacovigilancia, desde el 1 de enero de 2005 al 31 de ...
Leidy Santos Muñoz +1 more
doaj
Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas,1 Emilio J Sanz,2,3 Jose de Leon4,5 1Department of Internal Medicine, Dermatology, and Psychiatry and Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, La Laguna, Canary Islands, Spain; 2Department of Physical
De las Cuevas C, Sanz EJ, de Leon J
doaj
OBJETIVO: Identificar os principais medicamentos falsificados apreendidos pela Polícia Federal brasileira e os estados em que houve a apreensão. MÉTODOS: Estudo retrospectivo descritivo dos laudos periciais elaborados por Peritos Criminais da Polícia ...
Joseane Ames, Daniele Zago Souza
doaj
Introducing auto-disable syringes to the national immunization programme in Madagascar
OBJECTIVE: To evaluate the safety and coverage benefits of auto-disable (AD) syringes, weighed against the financial and logis- tical costs, and to create appropriate health policies in Madagascar.
Drain Paul K. +3 more
doaj
Manufacturing Barriers to Biologics Competition and Innovation [PDF]
As finding breakthrough small-molecule drugs gets harder, drug companies are increasingly turning to “large molecule” biologics. Although biologics represent many of the most promising new therapies for previously intractable diseases, they are extremely
Price, W. Nicholson, II, Rai, Arti K.
core +2 more sources
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON [PDF]
core +1 more source
Incentivizing Postmarketing Pharmaceutical Product Safety Testing with Extension of Exclusivity Periods [PDF]
Kushner, Leslie
core +1 more source

